Celeste Cagnazzo

1.2k total citations
56 papers, 758 citations indexed

About

Celeste Cagnazzo is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Celeste Cagnazzo has authored 56 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 21 papers in Public Health, Environmental and Occupational Health and 15 papers in Economics and Econometrics. Recurrent topics in Celeste Cagnazzo's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Ethics in Clinical Research (11 papers) and Biomedical Ethics and Regulation (9 papers). Celeste Cagnazzo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Ethics in Clinical Research (11 papers) and Biomedical Ethics and Regulation (9 papers). Celeste Cagnazzo collaborates with scholars based in Italy, United States and Switzerland. Celeste Cagnazzo's co-authors include Massimo Aglietta, Francesco Leone, Donatella Marino, Roberto Filippi, W. H. Miller, Cinzia Bagalá, Carlo Barone, Bo Huang, Giuliana Cavalloni and Alessandro Bonzano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Celeste Cagnazzo

46 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celeste Cagnazzo Italy 12 463 176 137 105 102 56 758
Wan‐Lun Hsu Taiwan 20 555 1.2× 319 1.8× 175 1.3× 81 0.8× 147 1.4× 59 1.1k
Majella B. Doyle United States 15 361 0.8× 496 2.8× 221 1.6× 79 0.8× 121 1.2× 38 1.0k
Vincenzo Montesarchio Italy 17 373 0.8× 108 0.6× 229 1.7× 47 0.4× 155 1.5× 69 847
John B. Liao United States 18 267 0.6× 253 1.4× 90 0.7× 188 1.8× 134 1.3× 43 933
Liam Grogan Ireland 18 424 0.9× 118 0.7× 164 1.2× 39 0.4× 281 2.8× 66 978
Eliano Cascardi Italy 15 245 0.5× 103 0.6× 122 0.9× 88 0.8× 196 1.9× 70 736
Mehdi Karkouri Morocco 14 186 0.4× 93 0.5× 93 0.7× 129 1.2× 135 1.3× 114 649
Ingolf Juhasz‐Böss Germany 15 219 0.5× 152 0.9× 87 0.6× 179 1.7× 146 1.4× 87 845
Ka Yu Tse Hong Kong 19 151 0.3× 134 0.8× 110 0.8× 59 0.6× 270 2.6× 77 1.3k

Countries citing papers authored by Celeste Cagnazzo

Since Specialization
Citations

This map shows the geographic impact of Celeste Cagnazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celeste Cagnazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celeste Cagnazzo more than expected).

Fields of papers citing papers by Celeste Cagnazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celeste Cagnazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celeste Cagnazzo. The network helps show where Celeste Cagnazzo may publish in the future.

Co-authorship network of co-authors of Celeste Cagnazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Celeste Cagnazzo. A scholar is included among the top collaborators of Celeste Cagnazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celeste Cagnazzo. Celeste Cagnazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cagnazzo, Celeste, et al.. (2025). Good clinical practice revision 3: evolution or revolution?. SHILAP Revista de lepidopterología. 12(1). 27–32.
3.
Fabbri, Francesca, Marta Betti, Raffaella Bertolotti, et al.. (2024). Perception of decentralized clinical trials and home nursing in oncology clinical research: insights from a survey of clinical research professionals across experimental sites. International Journal of Clinical Trials. 11(3). 162–169.
4.
5.
Cagnazzo, Celeste, et al.. (2023). Clinical trial units and clinical research coordinators: a system facing crisis?. SHILAP Revista de lepidopterología. 10. 1–3. 3 indexed citations
6.
Zucchetti, Giulia, et al.. (2023). How to manage symptoms in pediatric cancer patients enrolled in clinical trials? A review of principal patient-reported outcome screening tools. SHILAP Revista de lepidopterología. 10. 110–118. 1 indexed citations
7.
Cagnazzo, Celeste, et al.. (2023). ISO 9001:2015 standard implementation in clinical trial centers: An exploratory analysis of benefits and barriers in Italy. Contemporary Clinical Trials Communications. 33. 101104–101104. 3 indexed citations
8.
Farruggia, Piero, Marta Pillon, Maurizio Mascarin, et al.. (2023). Pediatric gray zone lymphoma according to the 2022 WHO classification: An Italian cohort study. Pediatric Blood & Cancer. 70(9). 1 indexed citations
9.
Cagnazzo, Celeste, et al.. (2023). 1719P Decentralized clinical trials: Is there a space in Italy?. Annals of Oncology. 34. S936–S937.
10.
Cagnazzo, Celeste, et al.. (2023). OFF-LABEL USE IN ITALY: IS THERE SPACE FOR HARMONIZATION?. 3(4). 165–165.
11.
Cagnazzo, Celeste. (2022). Implementazione del regolamento europeo 536/2014 in Italia: la storia infinita. Recenti Progressi in Medicina. 113(5). 299–304. 2 indexed citations
12.
Cavalera, Simone, Fabio Di Nardo, Matteo Chiarello, et al.. (2022). Bacterial ligands as flexible and sensitive detectors in rapid tests for antibodies to SARS-CoV-2. Analytical and Bioanalytical Chemistry. 414(18). 5473–5482. 4 indexed citations
13.
Cagnazzo, Celeste & Franca Fagioli. (2020). La burocrazia cede il passo alla scienza. Quel che di buono ci ha lasciato la pandemia. Recenti Progressi in Medicina. 111(10). 565–567. 3 indexed citations
14.
Cagnazzo, Celeste, et al.. (2020). Infermieri di ricerca in Italia: una figura indispensabile?. Recenti Progressi in Medicina. 111(9). 535–538. 3 indexed citations
15.
Cavalera, Simone, Barbara Colitti, Sergio Rosati, et al.. (2020). A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2. Talanta. 223(Pt 1). 121737–121737. 76 indexed citations
16.
Cagnazzo, Celeste, Alessandro Costanzo, Stefania Gori, et al.. (2020). Patient associations and clinical oncology research: how much does a patient’s voice really matter?. Expert Review of Pharmacoeconomics & Outcomes Research. 21(3). 433–440. 2 indexed citations
17.
Cagnazzo, Celeste, et al.. (2019). Ricerca clinica: abbastanza giocatori per vincere la partita?. Recenti Progressi in Medicina. 110(6). 285–291. 4 indexed citations
18.
Cagnazzo, Celeste, et al.. (2019). Coordinatori di ricerca clinica: una risorsa indispensabile. Recenti Progressi in Medicina. 110(2). 65–67. 8 indexed citations
19.
Cagnazzo, Celeste, et al.. (2017). Burnout syndrome: What impact on clinical research?. Annals of Oncology. 28. v510–v510. 2 indexed citations
20.
Marchesi, Emanuela, et al.. (2016). AIFA Determination 809/2015 on Phase I Clinical Trials: a new challenge for Italian Research. Annals of Oncology. 27. iv112–iv112. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026